血管内超声的使用与下肢外周动脉介入术后通畅率改善相关
基于VQI-PVI模块2016至2020年数据,纳入56,633例下肢外周动脉介入手术,比较使用与不使用血管内超声(IVUS)的1年结局。倾向性匹配后1,854例患者分析显示,IVUS-PVI组1年通畅率高于非IVUS组(97.7% vs 95.2%,P=0.004),主要截肢无显著差异。
要点
- 倾向性匹配后IVUS-PVI组1年通畅率97.7%,非IVUS组95.2%(P=0.004)。
- IVUS与1年截肢无显著关联(OR 1.7,95%CI 0.78-3.91)。
- IVUS是1年通畅的独立预测因素(OR 2.46,95%CI 1.43-4.25)。
核心结论
- 与单纯血管造影相比,下肢外周动脉介入中使用IVUS与1年通畅率改善相关。
- CLTI患者、病变长度>15 cm及TASC C或D病变亚组可能从辅助使用IVUS中获益。
研究设计与样本
- 回顾性分析血管质量倡议外周血管介入(VQI-PVI)模块2016至2020年数据。
- 共56,633例手术(非IVUS-PVI 55,302例 vs IVUS-PVI 1,331例),来自44,042例患者。
- 按人口学与合并症进行1:1倾向性匹配,匹配后队列共1,854例患者,基线无差异。
主要发现
- 匹配队列中间歇性跛行血运重建占60.4%,慢性肢体威胁性缺血(CLTI)占33.9%。
- IVUS更常用于长度>15 cm的病变(46.6% vs 43.3%)和主髂动脉病变(31.8% vs 27.2%)。
- IVUS-PVI组斑块旋切和支架置入率显著更高(21.1% vs 16.8%),球囊血管成形术更少(13.5% vs 24.4%)。
- IVUS-PVI组1年通畅率优于非IVUS组(97.7% vs 95.2%,P=0.004)。
- 亚组分析中,IVUS与CLTI患者、TASC C或D病变及治疗长度>15 cm的病变通畅率改善相关(OR 2.20,95%CI 1.29-3.75)。
关键数值与推荐
- 辅助使用IVUS与1年截肢无显著影响(OR 1.7,95%CI 0.78-3.91)。
- 多变量回归中,辅助使用IVUS(OR 2.46,95%CI 1.43-4.25)和主髂动脉介入(OR 2.91,95%CI 1.09-7.75)是通畅的独立预测因素。
- 斑块旋切、支架置入或球囊血管成形术等治疗方式对1年通畅率无显著影响。
临床怎么用
- 作者认为,下肢外周动脉介入中使用IVUS与1年通畅率改善相关。
- 作者认为,CLTI患者、病变长度>15 cm及TASC C或D病变亚组可能从辅助使用IVUS中获益。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intravascular ultrasound (IVUS) facilitates detailed visualization of endoluminal anatomy not adequately appreciated on conventional angiography. However, it is unclear if IVUS use improves clinical outcomes of peripheral vascular interventions (PVIs) for peripheral arterial disease. This study aimed to evaluate the impact of IVUS on 1-year outcomes of PVI in the vascular quality initiative (VQI). METHODS: The VQI-PVI modules were reviewed (2016-2020). All patients with available 1-year follow-up after lower extremity PVI were included and grouped as IVUS-PVI or non-IVUS PVI based on use of IVUS. Propensity matching (1:1) was performed using demographics and comorbidities. One-year major amputation and patency rates were compared. A generalized estimating equation model was used to identify predictors of 1-year outcomes. Subgroup analysis based on Trans-Atlantic Intersociety Consensus (TASC) classification, treatment length and treatment modalities were performed using same modeling approaches. RESULTS: There were 56,633 procedures (non-IVUS PVI = 55,302 vs. IVUS-PVI = 1,331) in 44,042 patients. Propensity matching yielded a total cohort of 1,854 patients matched (1:1), with no baseline differences. Lower extremity revascularization for claudication was performed in 60.4%, while one-third (33.9%) had chronic limb threatening ischemia (CLTI). IVUS was more commonly used for lesions >15 cm in length (46.6% vs. 43.3%) and for aortoiliac disease (31.8% vs. 27.2%). Rates of atherectomy and stenting were significantly higher with IVUS-PVI (21.1% vs. 16.8%), while balloon angioplasty was less common (13.5% vs. 24.4%). One-year patency was better with IVUS-PVI (97.7% vs. 95.2%, P = 0.004). On subgroup analysis, IVUS (odds ratio [OR] 2.20, 95% confidence interval [CI] 1.29-3.75) was associated with improved patency in CLTI patients, TASC C or D lesions, and treatment length >15 cm. Adjunctive IVUS use during PVI did not significantly impact 1-year amputation (OR 1.7, 95% CI 0.78-3.91). On multivariable regression, adjunctive use of IVUS (OR 2.46 95% CI 1.43-4.25) and aortoiliac interventions (OR 2.91, 95% CI 1.09-7.75) were independent predictors of patency. Treatment modalities such as atherectomy, stenting or balloon angioplasty did not significantly impact patency at 1-year. CONCLUSIONS: IVUS during lower extremity PVI is associated with improved 1-year patency, when compared to angiography alone. Certain subgroups, such as CLTI patients, lesions>15 cm, and TASC C or D lesions might benefit from adjunctive use of IVUS.
引用
- Brahmandam A, Kim TI, Parziale S, et al. Intravascular Ultrasound Use is Associated with Improved Patency in Lower Extremity Peripheral Arterial Interventions. Ann Vasc Surg. 2024. PMID: 38810722. doi:10.1016/j.avsg.2024.03.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。